Publicaciones (460) Publicaciones de Vivencio Vicente Barrios Alonso

2023

  1. Association between sacubitril/valsartan initiation and changes in left ventricular ejection fraction: Insights from ARIADNE registry

    International Journal of Cardiology, Vol. 370, pp. 279-286

  2. Cardiovascular Risk in Patients with Dyslipidemia and Their Degree of Control as Perceived by Primary Care Physicians in a Survey—TERESA-Opinion Study

    International Journal of Environmental Research and Public Health, Vol. 20, Núm. 3

  3. Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity

    Clinical and Translational Oncology, Vol. 25, Núm. 11, pp. 3073-3085

  4. Cost-effectiveness of the CNIC-Polypill versus separate monocomponents in cardiovascular secondary prevention in Spain

    Revista Clinica Espanola, Vol. 223, Núm. 7, pp. 414-422

  5. Current situation of the comprehensive approach of heart failure in Spain. The OPTIMISE-IC project

    REC: CardioClinics, Vol. 58, Núm. 4, pp. 289-302

  6. Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  7. Impact of COVID-19 pandemic on the sanitary assistance of atrial fibrillation in Spain

    REC: CardioClinics, Vol. 58, Núm. 3, pp. 241-244

  8. Impact of the Spanish consensus for improving lipid control on patients admitted for an acute coronary syndrome

    Journal of Clinical Lipidology, Vol. 17, Núm. 6, pp. 756-764

  9. Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban

    Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049

  10. Prevalence Rates of Arterial Hypertension According to the Threshold Criteria of 140/90 or 130/80 mmHg and Associated Cardiometabolic and Renal Factors: SIMETAP-HTN Study

    Medicina (Lithuania), Vol. 59, Núm. 10

  11. Real-World Attainment of Low-Density Lipoprotein Cholesterol Goals in Patients at High Risk of Cardiovascular Disease Treated with High-Intensity Statins: The TERESA Study

    Journal of Clinical Medicine, Vol. 12, Núm. 9

  12. SGLT 2 inhibitors: Searching for the best in class

    International Journal of Cardiology

  13. STRUGGLE FOR. Italian-Polish-Spanish-Uzbek--Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practice

    Cardiology Journal, Vol. 30, Núm. 6, pp. 859-869

  14. Selection of the best of 2022 in clinical cardiology and cardiovascular pharmacotherapy

    REC: CardioClinics, Vol. 58, pp. S49-S54